HEEMA BHAGAT: Open Payments
NPI 1275152282 · LONDONDERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 42 payments from 10 companies in 2025. Trend: 2023 $112 · 2024 $477 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $560 |
| Inspire Medical Systems, Inc. | 3 | $119 |
| Lilly USA, LLC | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Novo Nordisk Inc | 2 | $43 |
| Amgen Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| PFIZER INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: UBRELVY, QULIPTA, INSPIRE, BREZTRI, JARDIANCE, Ozempic, REPATHA, ROTATEQ.
Industry payments across NH — which companies pay providers there.
